标题
Hereditary Prostate Cancer: Genes Related, Target Therapy and Prevention
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 22, Issue 7, Pages 3753
出版商
MDPI AG
发表日期
2021-04-05
DOI
10.3390/ijms22073753
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Quantitative and Qualitative Analysis of Blood-based Liquid Biopsies to Inform Clinical Decision-making in Prostate Cancer
- (2021) Irene Casanova-Salas et al. EUROPEAN UROLOGY
- Genetic predisposition to prostate cancer: an update
- (2021) Holly Ni Raghallaigh et al. Familial Cancer
- Prevalence of mutations in BRCA and MMR genes in patients affected with hereditary endometrial cancer
- (2021) Maria Teresa Vietri et al. MEDICAL ONCOLOGY
- Genetic Testing in Prostate Cancer
- (2020) Alexandra O. Sokolova et al. Current Oncology Reports
- ATM Serine/Threonine Kinase and its Role in Pancreatic Risk
- (2020) Neha Nanda et al. Genes
- Diagnosing hereditary cancer predisposition in men with prostate cancer
- (2020) Mary Pritzlaff et al. GENETICS IN MEDICINE
- Olaparib for Metastatic Castration-Resistant Prostate Cancer
- (2020) Johann de Bono et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inherited DNA Repair Gene Mutations in Men with Lethal Prostate Cancer
- (2020) Tommi Rantapero et al. Genes
- Molecular Trajectory of BRCA1 and BRCA2 Mutations
- (2020) Yuichiro Hatano et al. Frontiers in Oncology
- Hereditary Predisposition to Prostate Cancer: From Genetics to Clinical Implications
- (2020) Andreia Brandão et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Germline HOXB13 G84E mutation carriers and risk to twenty common types of cancer: results from the UK Biobank
- (2020) Jun Wei et al. BRITISH JOURNAL OF CANCER
- Five Italian Families with Two Mutations in BRCA Genes
- (2020) Maria Teresa Vietri et al. Genes
- BRCA2 and Other DDR Genes in Prostate Cancer
- (2019) Paz Nombela et al. Cancers
- Prevalence of Germline Variants in Prostate Cancer and Implications for Current Genetic Testing Guidelines
- (2019) Piper Nicolosi et al. JAMA Oncology
- Targeting DNA Repair Defects for Precision Medicine in Prostate Cancer
- (2019) Alejandro Athie et al. Current Oncology Reports
- Exploiting DNA repair defects in colorectal cancer
- (2019) Nicole M. Reilly et al. Molecular Oncology
- Bringing prostate cancer germline genetics into clinical practice
- (2019) Sanjay Das et al. JOURNAL OF UROLOGY
- Treatment of Advanced Prostate Cancer
- (2019) Min Yuen Teo et al. Annual Review of Medicine
- A Rich Array of Prostate Cancer Molecular Biomarkers: Opportunities and Challenges
- (2019) Indu Kohaar et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Germline and Somatic Mutations in Prostate Cancer for the Clinician
- (2019) Heather H. Cheng et al. Journal of the National Comprehensive Cancer Network
- Genomic correlates of clinical outcome in advanced prostate cancer
- (2019) Wassim Abida et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- PARP Inhibitors in Prostate Cancer—The Preclinical Rationale and Current Clinical Development
- (2019) Virtanen et al. Genes
- First-degree family history of breast cancer is associated with prostate cancer risk: a systematic review and meta-analysis
- (2019) Zheng-Ju Ren et al. BMC CANCER
- Interim Results from the IMPACT Study: Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers
- (2019) Elizabeth C. Page et al. EUROPEAN UROLOGY
- Formal Methods for Prostate Cancer Gleason Score and Treatment Prediction using Radiomic Biomarkers
- (2019) Luca Brunese et al. MAGNETIC RESONANCE IMAGING
- Towards precision oncology in advanced prostate cancer
- (2019) Sheng-Yu Ku et al. Nature Reviews Urology
- Hereditary prostate cancer – Primetime for genetic testing?
- (2019) Isabel Heidegger et al. CANCER TREATMENT REVIEWS
- Prostate-specific antigen velocity in a prospective prostate cancer screening study of men with genetic predisposition
- (2018) Christos Mikropoulos et al. BRITISH JOURNAL OF CANCER
- Genetic testing for hereditary prostate cancer: Current status and limitations
- (2018) Jun Tu Zhen et al. CANCER
- Germline DNA-repair Gene Mutations and Outcomes in Men with Metastatic Castration-resistant Prostate Cancer Receiving First-line Abiraterone and Enzalutamide
- (2018) Emmanuel S. Antonarakis et al. EUROPEAN UROLOGY
- Prostate Cancer Genomics: Recent Advances and the Prevailing Underrepresentation from Racial and Ethnic Minorities
- (2018) Shyh-Han Tan et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Screening for Prostate Cancer
- (2018) et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Role of Genetic Testing for Inherited Prostate Cancer Risk: Philadelphia Prostate Cancer Consensus Conference 2017
- (2018) Veda N. Giri et al. JOURNAL OF CLINICAL ONCOLOGY
- The Genomics of Prostate Cancer: A Historic Perspective
- (2018) Mark A. Rubin et al. Cold Spring Harbor Perspectives in Medicine
- Targeted next generation sequencing identifies functionally deleterious germline mutations in novel genes in early-onset/familial prostate cancer
- (2018) Paula Paulo et al. PLoS Genetics
- PD-1/PD-L1 pathway inhibitors in advanced prostate cancer
- (2018) Pedro Isaacsson Velho et al. Expert Review of Clinical Pharmacology
- Genomic Hallmarks and Structural Variation in Metastatic Prostate Cancer
- (2018) David A. Quigley et al. CELL
- Genomic Analysis of Three Metastatic Prostate Cancer Patients with Exceptional Responses to Carboplatin Indicating Different Types of DNA Repair Deficiency
- (2018) Zafeiris Zafeiriou et al. EUROPEAN UROLOGY
- Clinical Features and Therapeutic Outcomes in Men with Advanced Prostate Cancer and DNA Mismatch Repair Gene Mutations
- (2018) Emmanuel S. Antonarakis et al. EUROPEAN UROLOGY
- Cell-free DNA profiling of metastatic prostate cancer reveals microsatellite instability, structural rearrangements and clonal hematopoiesis
- (2018) Markus Mayrhofer et al. Genome Medicine
- Germline Mutations in ATM and BRCA1/2 Distinguish Risk for Lethal and Indolent Prostate Cancer and are Associated with Early Age at Death
- (2017) Rong Na et al. EUROPEAN UROLOGY
- Next-Generation Sequencing in Oncology: Genetic Diagnosis, Risk Prediction and Cancer Classification
- (2017) Rick Kamps et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Validation of a Next-Generation Sequencing Pipeline for the Molecular Diagnosis of Multiple Inherited Cancer Predisposing Syndromes
- (2017) Paula Paulo et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
- (2017) Dung T. Le et al. SCIENCE
- Prostate Cancer Genetics: Variation by Race, Ethnicity, and Geography
- (2017) Timothy R. Rebbeck SEMINARS IN RADIATION ONCOLOGY
- Men with family history of prostate cancer have a higher risk of disease recurrence after radical prostatectomy
- (2017) Mark Thalgott et al. WORLD JOURNAL OF UROLOGY
- Prostate Cancer Germline Variations and Implications for Screening and Treatment
- (2017) Alexander Dias et al. Cold Spring Harbor Perspectives in Medicine
- PSA and Prostate Health Index based prostate cancer screening in a hereditary migration complicated population: implications in precision diagnosis
- (2017) Mariyam Akizhanova et al. Journal of Cancer
- Prevalence of theHOXB13G84E mutation in Danish men undergoing radical prostatectomy and its correlations with prostate cancer risk and aggressiveness
- (2016) Tine M. Storebjerg et al. BJU INTERNATIONAL
- Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer
- (2016) Colin C. Pritchard et al. NEW ENGLAND JOURNAL OF MEDICINE
- Familial prostate cancer
- (2016) Veda N. Giri et al. SEMINARS IN ONCOLOGY
- High burden of copy number alterations andc-MYCamplification in prostate cancer fromBRCA2germline mutation carriers
- (2015) E. Castro et al. ANNALS OF ONCOLOGY
- The HOXB13 G84E Mutation Is Associated with an Increased Risk for Prostate Cancer and Other Malignancies
- (2015) J. L. Beebe-Dimmer et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Analysis of PALB2 in a cohort of Italian breast cancer patients: identification of a novel PALB2 truncating mutation
- (2015) Maria Teresa Vietri et al. Familial Cancer
- Pathogenic and likely pathogenic variant prevalence among the first 10,000 patients referred for next-generation cancer panel testing
- (2015) Lisa R. Susswein et al. GENETICS IN MEDICINE
- Germline Mutations in the BRIP1, BARD1, PALB2, and NBN Genes in Women With Ovarian Cancer
- (2015) Susan J. Ramus et al. JNCI-Journal of the National Cancer Institute
- DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer
- (2015) Joaquin Mateo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Germline Mutations in the BRIP1, BARD1, PALB2, and NBN Genes in Women With Ovarian Cancer
- (2015) Susan J. Ramus et al. JNCI-Journal of the National Cancer Institute
- Frequent germline deleterious mutations in DNA repair genes in familial prostate cancer cases are associated with advanced disease
- (2014) D Leongamornlert et al. BRITISH JOURNAL OF CANCER
- Prostate cancer incidence in males with Lynch syndrome
- (2014) Sigurdis Haraldsdottir et al. GENETICS IN MEDICINE
- A practice guideline from the American College of Medical Genetics and Genomics and the National Society of Genetic Counselors: referral indications for cancer predisposition assessment
- (2014) Heather Hampel et al. GENETICS IN MEDICINE
- The G84E mutation of HOXB13 is associated with increased risk for prostate cancer: results from the REDUCE trial
- (2013) Z. Chen et al. CARCINOGENESIS
- A genome-wide association study of prostate cancer in West African men
- (2013) Michael Blaise Cook et al. HUMAN GENETICS
- Germline Mutations inHOXB13and Prostate-Cancer Risk
- (2012) Charles M. Ewing et al. NEW ENGLAND JOURNAL OF MEDICINE
- Phosphorylation-regulated binding of Ctp1 to Nbs1 is critical for repair of DNA double-strand breaks
- (2011) Gerald E. Dodson et al. CELL CYCLE
- Prostate cancer in BRCA2 germline mutation carriers is associated with poorer prognosis
- (2010) S M Edwards et al. BRITISH JOURNAL OF CANCER
- Germline BRCA Mutations Denote a Clinicopathologic Subset of Prostate Cancer
- (2010) D. J. Gallagher et al. CLINICAL CANCER RESEARCH
- The DNA Damage Response: Making It Safe to Play with Knives
- (2010) Alberto Ciccia et al. MOLECULAR CELL
- DNA damage and decisions: CtIP coordinates DNA repair and cell cycle checkpoints
- (2010) Zhongsheng You et al. TRENDS IN CELL BIOLOGY
- A recurrent truncating germline mutation in the BRIP1/FANCJ gene and susceptibility to prostate cancer
- (2009) Z Kote-Jarai et al. BRITISH JOURNAL OF CANCER
- Associations of High-Grade Prostate Cancer with BRCA1 and BRCA2 Founder Mutations
- (2009) I. Agalliu et al. CLINICAL CANCER RESEARCH
- PALB2 Regulates Recombinational Repair through Chromatin Association and Oligomerization
- (2009) Shirley M.-H. Sy et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The DNA-damage response in human biology and disease
- (2009) Stephen P. Jackson et al. NATURE
- BRCA1 and its toolbox for the maintenance of genome integrity
- (2009) Michael S.Y. Huen et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Prostate cancer in male BRCA1 and BRCA2 mutation carriers has a more aggressive phenotype
- (2008) A Mitra et al. BRITISH JOURNAL OF CANCER
- The MRN complex
- (2008) Agnieszka Rupnik et al. CURRENT BIOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started